Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Blood ◽

10.1182/blood-2017-01-764258 ◽

2017 ◽

Vol 129 (16) ◽

pp. 2328-2330 ◽

Author(s):

Pier Luigi Zinzani ◽

Cinzia Pellegrini ◽

Annalisa Chiappella ◽

Alice Di Rocco ◽

Flavia Salvi ◽

...

Keyword(s):

Clinical Trial ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Large B Cell Lymphoma ◽

Phase 2 Clinical Trial ◽

Download Full-text

A phase 2 clinical trial testing DPX-Survivac and metronomic low dose cyclophosphamide as immunotherapy for patients with recurrent diffuse large b-cell lymphoma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e14578 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e14578-e14578 ◽

Author(s):

Neil Lorne Berinstein ◽

Richard H. C. Van Der Jagt ◽

Matthew C. Cheung ◽

Rena Buckstein ◽

Mohan Karkada ◽

...

Keyword(s):

Clinical Trial ◽

B Cell ◽

Low Dose ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Phase 2 ◽

Large B Cell Lymphoma ◽

Trial Testing ◽

Phase 2 Clinical Trial ◽

Download Full-text

NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE 2 CHECKMATE 436 STUDY

Hematological Oncology ◽

10.1002/hon.114_2629 ◽

2019 ◽

Vol 37 ◽

pp. 157-158

Author(s):

P.L. Zinzani ◽

A. Santoro ◽

G. Gritti ◽

P. Brice ◽

P.M. Barr ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Efficacy And Safety ◽

Large B Cell Lymphoma ◽

Download Full-text

Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.07.262 ◽

2019 ◽

Vol 19 ◽

pp. S303

Author(s):

Pier Luigi Zinzani ◽

Armando Santoro ◽

Guiseppe Gritti ◽

Pauline Brice ◽

Paul M. Barr ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Efficacy And Safety ◽

Large B Cell Lymphoma ◽

Download Full-text

NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY

Hematological Oncology ◽

10.1002/hon.51_2879 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

P. L. Zinzani ◽

A. Santoro ◽

G. Gritti ◽

P. Brice ◽

P. M. Barr ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Large B Cell Lymphoma ◽

Download Full-text

EVALUATION OF BONE MARROW INFILTRATION BY MULTIDIMENSIONAL FLOW CYTOMETRY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: SUB-STUDY OF A PHASE 2 GELTAMO CLINICAL TRIAL

Hematological Oncology ◽

10.1002/hon.26_2631 ◽

2019 ◽

Vol 37 ◽

pp. 362-364 ◽

Author(s):

M. Baile ◽

S. Barrena ◽

J. Sancho ◽

C. Grande ◽

R. Fernández ◽

...

Keyword(s):

Clinical Trial ◽

Bone Marrow ◽

Flow Cytometry ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Bone Marrow Infiltration ◽

Phase 2 ◽

Large B Cell Lymphoma ◽

Download Full-text

S1601 NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE 2 CHECKMATE 436 STUDY

10.1097/01.hs9.0000564652.16751.86 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 737

Author(s):

P.L. Zinzani ◽

A. Santoro ◽

G. Gritti ◽

P. Brice ◽

P.M. Barr ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Efficacy And Safety ◽

Large B Cell Lymphoma ◽

Download Full-text

ABCL-454: CheckMate 436: Extended Follow-Up from the Phase 2 Study Investigating Nivolumab Plus Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01901-7 ◽

2021 ◽

Vol 21 ◽

pp. S398-S399

Author(s):

Pier Luigi Zinzani ◽

Armando Santoro ◽

Giuseppe Gritti ◽

Pauline Brice ◽

Paul Barr ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Large B Cell Lymphoma ◽

Phase 2 Study ◽

Download Full-text

Poster: ABCL-454: CheckMate 436: Extended Follow-Up from the Phase 2 Study Investigating Nivolumab Plus Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01520-2 ◽

2021 ◽

Vol 21 ◽

pp. S242

Author(s):

Pier Luigi Zinzani ◽

Armando Santoro ◽

Giuseppe Gritti ◽

Pauline Brice ◽

Paul Barr ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Large B Cell Lymphoma ◽

Phase 2 Study ◽

Download Full-text

16 / Axicabtagene Ciloleucel in Patients With Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1

10.26226/morressier.5b3b802db1b87b000eceda9c ◽

2018 ◽

Author(s):

Locke Frederick L.

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Phase 2 ◽

Pivotal Phase ◽

Large B Cell Lymphoma ◽

Phase 2 Study ◽

Download Full-text

Faculty Opinions recommendation of Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10103963.10867063 ◽

2011 ◽

Author(s):

Lazzaro M Repetto

Keyword(s):

Elderly Patients ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Phase 2 ◽

Phase 2 Trial ◽

Large B Cell Lymphoma ◽

Download Full-text